An Introduction to the Therapeutic Frame

For neurodegenerative diseases, the impact of immunological markers is one of the modern research areas. It has been observed that neuroinflammation increases the cellular precipitation of some of the key proteins associated with neurodegenerative diseases. Therefore, the possibility of functional loss can be enhanced due to neuroinflammation which leads to the initiation of any related diseases. In this regard, autoantibodies, which are known for their autophagy nature, can be considered as key elements for early diagnostic as well as early therapeutics. In this article, we have proposed a comprehensive framework to unveil the diagnostic as well as the therapeutic possibility of the autoantibodies which are largely associated with Mild-Moderate Alzheimer's Disease, Early-Stage Parkinson's Disease, and Multiple Sclerosis. Here, we have introduced a new concept of average p-value where multiple p-values of an autoantibody in a singular disease have been considered as a multi-occurrence of that sample in cellular systems. Also, multiple proteins from a single protein family under a differentially expressed range have been prioritized. As a result, the top ten autoantibodies have been selected for further study and also considered as diagnostic markers. Interestingly, most of the selected autoantibodies are either cytokines or immunoglobulins. Subsequently, we have performed an evolutionary sequence-structure space study to identify the druggable structural facet for the selected autoantibodies. To make the therapeutic perspective more robust, we have introduced the concept of protein moonlighting. Hence, it provides more robustness in therapeutic identification. Finally, two autoantibodies i.e., Q9NYV4 and P01602 are identified as a novel marker.

Download Full-text

The Case of "Rosa": Reflections on the Treatment of a Survivor of Relational Trauma

Pragmatic Case Studies in Psychotherapy ◽

10.14713/pcsp.v14i1.2035 ◽

2018 ◽

Vol 14 (1) ◽

pp. 77

Author(s):

Nicole Vigoda Gonzales

Keyword(s):

Change Process ◽

Clinical Skills ◽

Psychological Needs ◽

Emotional Experiences ◽

Language Switching ◽

Short Term ◽

Emotional Change ◽

Relational Trauma ◽

Flexible Adaptation ◽

Therapeutic Frame

In this article, I respond to commentaries by Karen Riggs Skean (2018) and Shigeru Iwakabe (2018) on my presentation of the case of "Rosa," (Vigoda Gonzalez, 2018), a survivor of chronic relational trauma. In her insightful response, Riggs Skean (2018) elaborates on the interplay between language switching and the therapeutic frame, the suitability of Accelerated Experiential Dynamic Psychotherapy (AEDP; Fosha, 2000) for the treatment of trauma, and the short-term nature of the work with this particular client. Iwakabe (2018), an AEDP clinician and researcher, offers insights and reflections on the areas of language switching, emotional change process, and corrective emotional experiences, and poses evocative questions regarding the development of clinical skills relevant to affect-focused therapies. In the following response I consider these thoughtful commentaries and provide feedback with the hope to spur the dialogue regarding the flexible adaptation of treatment approaches to our clients’ psychological needs.

Download Full-text

The Influence of the Therapeutic Frame of Reference on the Evaluation of the First Sessions of Psychotherapy: A Pilot Study

Psychologica Belgica ◽

10.5334/pb.789 ◽

1989 ◽

Vol 29 (1) ◽

pp. 63

Author(s):

Chantal Van Audenhove ◽

Hans Vertommen ◽

Walter Vandereycken

Keyword(s):

Pilot Study ◽

Frame Of Reference ◽

Therapeutic Frame

Download Full-text